Dr. Keith C. Bible, MD, PhD

  • Rochester, MN
  • Medical oncologist
NPI1497733216
Medicare services, 2020
35,336
Part D claims, 2021
70
Publications
67
Clinical trials
8
Industry payments
$3,028
Practice address
200 1st St Sw, Rochester, MN 55905-0001
Practice phone
Call (507) 284-2511
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Bible's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Keith C. Bible is a medical oncologist in Rochester, Minnesota

Dr. Bible practices in Rochester, Minnesota.

Dr. Bible's NPI, 1497733216, was assigned on January 3, 2006. Dr. Bible graduated from University of Illinois College of Medicine - Chicago in 1983. Dr. Bible's Minnesota license number on file is 33732.

NPI and contact details
NPI enumeration date
January 3, 2006
NPI status
Active
Practice phone
(507) 284-2511
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
1983

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Keith C. Bible's practice address is in Rochester, Minnesota

Dr. Bible's practice address in the NPI Registry is 200 1st St Sw, Rochester, MN 55905-0001. The practice phone is (507) 284-2511.

  • NPI Registry address
    200 1st St Sw, Rochester, MN 55905-0001Phone(507) 284-2511

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Keith C. Bible's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bible practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Bible's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bible practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Keith C. Bible is one of 122 medical oncologists in Minnesota

Medical oncology is Dr. Bible's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Bible has a license on file in Minnesota.

Specialties and state licenses

  • Medical oncology, MinnesotaPrimaryLicense 33732 · 1990 to 2025 · taxonomy 207RX0202X

Medical oncologists near Dr. Bible

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Keith C. Bible billed Medicare for 35,336 services in 2020

CMS data shows 35,336 Medicare services from Dr. Bible across 44 procedure codes in 2020. Medicare paid $905,726 for them. Every service was in an office.

Medicare services, 202035,336
Paid by Medicare$905,726
Procedure codes44

Dr. Bible's Medicare services by type, 2019 to 2020

  • 2019
  • 2020
Drugs given in the office
2019: 14,8082020: 34,031130%
Tests and treatments
2019: 6692020: 90035%
Office and hospital visits
2019: 3192020: 38521%
Other services
2019: 132020: 2054%

Dr. Bible compared with the Minnesota median for medical oncologists, 2020

  • Dr. Bible
  • Minnesota median
Medicare services
35,336vs 1,28427.5 times
Part D claims
70vs 19664% below

Medians across 119 medical oncologists in Minnesota with Dmand AI profiles that report each measure.

Dr. Bible's most billed Medicare procedure codes, 2020

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bible

Need commercial claims for Dr. Bible?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bible and other medical oncologists in Minnesota.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Keith C. Bible's patients have a median age of 88

Across all payers, Dmand AI patient panel data puts Dr. Bible's median patient age at 88, with 100% women.

Dr. Bible's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 88

Patient panel by sex, all payers

  • Women100%
  • Men0%

Source: Dmand AI Patient Panel Data

Dr. Keith C. Bible wrote 70 Medicare Part D claims in 2021

In 2021, Dr. Bible wrote 70 Medicare Part D claims. They cover 4 drugs, with $61,034 in total drug cost. In 2020, CMS named 712 claims across 25 drugs.

Part D claims, 202170
Drugs named by CMS4
Total drug cost$61,034

Dr. Bible's most prescribed drugs by claims, 2021

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2020 to 2021

  • 2020
  • 2021
Claims for drugs CMS names
2020: 7122021: 7090%

Drugs named by CMS: 4 in 2021, 25 in 2020.

See all prescribing by Dr. Bible

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Bible by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Keith C. Bible has 67 publications on record

Dmand AI links 67 papers to Dr. Bible, published from 2006 to 2024. 2017 was the busiest year, with 9. The most frequent topics are Thyroid Neoplasms, Antineoplastic Agents and Protein Kinase Inhibitors. Dr. Bible has published most often in J Clin Endocrinol Metab. Dr. Bible's most frequent co-authors are Ashish V. Chintakuntlawar, MD, PhD, Mabel M. Ryder, MD and Robert Smallridge, MD.

Papers67
Years published2006 to 2024

Dr. Bible's papers by year, 2014 to 2024

Topics Dr. Bible writes about most

  • Thyroid Neoplasms
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Thyroid Carcinoma, Anaplastic
  • Antineoplastic Combined Chemotherapy Protocols
  • Pyrimidines
  • Indazoles
  • Sulfonamides

Dr. Bible's most frequent co-authors

Recent publications by Dr. Bible

See all 67 publications and co-authors

See who Dr. Bible researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bible works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Keith C. Bible has worked on 8 clinical trials

Dmand AI links Dr. Bible to 8 clinical trials, 4 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Melanoma, Paraganglioma, Extra-Adrenal and Thyroid cancer, Hurthle cell. National Cancer Institute (NCI) sponsors the most, 6.

Clinical trials with Dr. Bible by phase

  1. 4Phase 1: 4 trials
  2. 4Phase 2: 4 trials
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Bible's trials

  • Melanoma
  • Paraganglioma, Extra-Adrenal
  • Thyroid cancer, Hurthle cell
  • Thyroid Carcinoma, Anaplastic
  • Adenocarcinoma, Follicular

Investigators on the most trials with Dr. Bible

Recent clinical trials with Dr. Bible

See all 8 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Keith C. Bible received $3,028 in industry payments from 2016 to 2017

CMS Open Payments shows 3 general payments to Dr. Bible from 2 drug and device companies from 2016 to 2017. Consulting fees make up the largest share, 94% of the total. Sanofi and Genzyme US Companies paid the most, $2,928.

General payments to Dr. Bible by program year, 2016 to 2017

General payments to Dr. Bible by kind, 2016 to 2017

$3Kin total
  • Consulting fees$2,83394%
  • Food and beverage$1956%

Companies that paid Dr. Bible the most, 2016 to 2017

Share is of all general payments to this clinician.

See all payments to Dr. Bible

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Keith C. Bible has 1 award and honors on record

Dmand AI lists 1 award for Dr. Bible, most recently Regional Top Doctor in 2014.

Awards and honors for Dr. Bible

  1. 2014
    • Regional Top Doctor

Source: Dmand AI Professional Profile Data

Dr. Keith C. Bible graduated from University of Illinois College of Medicine - Chicago

Dr. Bible graduated from University of Illinois College of Medicine - Chicago in 1983. Dr. Bible is a member of AACR, ASCO, ATA and ENDO.

  1. Medical schoolUniversity of Illinois College of Medicine - Chicago

Source: Dmand AI Professional Profile Data

Dr. Keith C. Bible accepts plans from 2 insurance carriers

Dr. Bible is in network with 2 carriers, including Aetna and WI State Medicaid. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • Aetna
  • WI State Medicaid

Plan types Dr. Bible accepts, by number of carriers

  1. EPO1
  2. HMO1
  3. Medicaid1
  4. Medicare1
  5. POS1
  6. PPO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Keith C. Bible's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Keith C. Bible

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Keith C. Bible's NPI number?

Dr. Keith C. Bible's NPI number is 1497733216. It was assigned on January 3, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Keith C. Bible?

Dr. Keith C. Bible is a medical oncologist in Rochester, Minnesota. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Keith C. Bible practice?

Dr. Bible practices at 200 1st St Sw, Rochester, MN 55905-0001.

What is Dr. Keith C. Bible's office phone number?

The practice phone on file for Dr. Bible is (507) 284-2511.

What is Dr. Keith C. Bible's medical license number?

Dr. Bible's Minnesota license number on file is 33732.

Does Dr. Keith C. Bible accept Medicare?

Yes. CMS data shows Dr. Bible billed Medicare for 35,336 services in 2020.

What services does Dr. Keith C. Bible bill to Medicare?

In 2020, Dr. Bible's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J9299) and injected or infused drug (J9263).

Where did Dr. Keith C. Bible go to medical school?

Dr. Bible graduated from University of Illinois College of Medicine - Chicago in 1983.

What drugs does Dr. Keith C. Bible prescribe most?

In 2021 Medicare Part D data, Dr. Bible's most prescribed drugs by claims were Levothyroxine Sodium, Omeprazole and Votrient.

Has Dr. Keith C. Bible received payments from drug or device companies?

CMS Open Payments shows $3,028 in general payments to Dr. Bible from 2 companies from 2016 to 2017. The largest total came from Sanofi and Genzyme US Companies.

Show 4 more questionsShow fewer questions

How long has Dr. Keith C. Bible been practicing?

Dr. Bible graduated from medical school in 1983, 43 years ago.

Does Dr. Keith C. Bible do research?

Dmand AI links 67 publications to Dr. Bible, published from 2006 to 2024. Dr. Bible has worked on 8 clinical trials.

Who does Dr. Keith C. Bible publish with?

Dr. Bible's most frequent co-authors are Ashish V. Chintakuntlawar, MD, PhD (14 shared papers), Mabel M. Ryder, MD (14 shared papers) and Robert Smallridge, MD (12 shared papers).

What insurance does Dr. Keith C. Bible accept?

Dr. Bible is in network with 2 carriers, including Aetna and WI State Medicaid. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Minnesota by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)